GameStop Earnings Disappoint, U.S & China Reach 'Framework' for Trade Deal
The Rundown
00:00
Pharma Giants Clash Over Weight Loss Drugs and Market Strategies
This chapter explores the rivalry in the weight loss drug market between pharmaceutical giants Eli Lilly and Novo Nordisk. It details Eli Lilly's stringent tactics against generic drug partnerships and contrasts them with Novo Nordisk's more collaborative strategies while examining the broader market implications on stock performances.
Transcript
Play full episode
